- Market Growth Factors & Global Market Size.
- Leading Players & Top Segments.
- Geographic Overview.
Market growth influenced due to following factors-
- High demand for emergency care,
- Increasing incidence of trauma injuries,
- Growing investments by government bodies on healthcare infrastructure development (including the establishment of and improvements in emergency care infrastructure)
Global market size-
According to research report the EMS products market is expected to reach $25.56 billion by 2022, at a CAGR of 6.1%.
Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US).
Top Market Segments-
By type, the EMS products market is classified into life support and emergency resuscitation equipment, patient monitoring systems, wound care consumables, patient handling equipment, infection control supplies, personal protection equipment, and other EMS products.
On the basis of end users, the EMS products market is segmented into hospitals & trauma centers, ambulatory surgical centers, and other end users.
By application, the market is segmented into cardiac care, trauma injuries, respiratory care, oncology, and other applications. The cardiac care segment is anticipated to account for the largest share of the global EMS products market in 2017.
For Details, Download PDF Brochure Here
North America is estimated to dominate the emergency medical services products market in 2017. The large share of this regional segment can primarily be attributed to the rising number of emergency visits, rising geriatric population, increasing healthcare expenditure, improving hospital infrastructure, technological advancements, and the strong presence of major players in the region.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.